Related references
Note: Only part of the references are listed.Circulating Tumor Cells and Circulating Tumor DNA
Catherine Alix-Panabieres et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Progress in circulating tumor cell capture and analysis: implications for cancer management
Marija Balic et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry
Ningfang Wang et al.
TUMOR BIOLOGY (2012)
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
Francois-Clement Bidard et al.
BREAST CANCER RESEARCH (2012)
High-Throughput Selection, Enumeration, Electrokinetic Manipulation, and Molecular Profiling of Low-Abundance Circulating Tumor Cells Using a Microfluidic System
Udara Dharmasiri et al.
ANALYTICAL CHEMISTRY (2011)
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
George Somlo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Christina Scheel et al.
CELL (2011)
Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
Monica M. Reinholz et al.
CLINICAL CANCER RESEARCH (2011)
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
Emiel Rutgers et al.
EUROPEAN JOURNAL OF CANCER (2011)
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype
James M. Reuben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells
Ibrahim Younos et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?
Christina Scheel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
Hisae Iinuma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method
Ming-Je Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
Erika Resetkova et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
Changes of HER2 Status in Circulating Tumor Cells Compared With the Primary Tumor During Treatment for Advanced Breast Cancer
Elisabetta Munzone et al.
CLINICAL BREAST CANCER (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
Disseminated tumor cells as biomarkers for breast cancer
Marija Balic
BIOMARKERS IN MEDICINE (2009)
Cancer stem cells in breast cancer and metastasis
Jessica C. Lawson et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
Nikolaos Xenidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer
Martin Buess et al.
NEOPLASIA (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Variation of circulating tumor cell levels during treatment of metastatic breast cancer:: prognostic and therapeutic implications
F. Nole et al.
ANNALS OF ONCOLOGY (2008)
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer
Michail Ignatiadis et al.
CLINICAL CANCER RESEARCH (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
Jo Anne Zujewski et al.
FUTURE ONCOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inflammatory cell infiltration of tumors: Jekyll or Hyde
James E. Talmadge et al.
CANCER AND METASTASIS REVIEWS (2007)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Marija Balic et al.
CLINICAL CANCER RESEARCH (2006)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Leukaemia stem cells and the evolution of cancer-stem-cell research
BJP Huntly et al.
NATURE REVIEWS CANCER (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients:: Evaluation of morphological categories and the number of clinically significant cells
B Naume et al.
CLINICAL CANCER RESEARCH (2004)
Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis
JJ Gaforio et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
